Deep sequencing analysis of hepatitis B virus in patients with incomplete response to tenofovir alafenamide fumarate treatment

Table 1 Baseline characteristics of patients

Patients	n = 13
Sex (male/female)	8/5
Age (year), median (range)	40 (30–62)
Genotype (A/B/C)	1/0/12
HBsAg (IU/mL), median (range)	5037.79 (605.77-139448.20)
Positive for HBeAg	8 (61.5%)
ALT (U/L), median (range)	64 (24–591)
HBV DNA (log IU/mL), median (range)	6.6 (1.6–9.1)

ALT: Alanine aminotransferase; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B e antigen; HBV: Hepatitis B virus.